Pay in 4 interest-free payments of $5.30 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
UK patients should understand that: Available evidence is largely from Phase 2 studies with relatively short follow-up periods Long-term cardiovascular outcome data are not yet available for either agent Phase 3 trials are ongoing, and results will inform future regulatory submissions to the MHRA UK patients interested in accessing these treatments through clinical trials may wish to consult the NIHR 'Be Part of Research' portal (bepartofresearch.nihr.ac.uk) or ClinicalTrials.gov for current recruitment opportunities
Long-term METH use increases H3 acetylation in the brain, decreasing H3K9ac and H3K18ac while increasing H4K5 and H4K8 acetylation over time
This report highlights the importance of correctly diagnosing BP etiology for guiding precise treatment
Liposomal Liposomal delivery allows for better absorption and stability in the body
Reactive protein isoforms differ in their effects on thrombus growth
